| 750568 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Abstracts |
2021-10-01 |
10.1136/jitc-2021-itoc8.abstracts |
|
| 750567 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P03.03 Novel machine-learning tools improve cost-effective development of personalised immunotherapies: lowering false positive rates in the search for actionable immunogenic neoantigens |
2021-10-01 |
10.1136/jitc-2021-itoc8.26 |
Bogaert C, Van Oudenhove L, Pfitzer L, Mill N, Fant B |
| 750566 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.04 Tissue-infiltrating Th9 cells in human endometrial cancer |
2021-10-01 |
10.1136/jitc-2021-itoc8.16 |
Tong H, Feng H, Wan X |
| 750565 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.02 Single-cell RNA sequencing of neuroblastoma tumors reveals immunoregulatory interactions as novel targets for immunotherapy |
2021-10-01 |
10.1136/jitc-2021-itoc8.14 |
Wienke J, Kholosy WM, Visser LL, Keller KM, Lijnzaad P, Margaritis T, Langenberg KPS, De Krijger RR, Holstege FCP, Molenaar JJ |
| 750564 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.04 Lentiviral protein Vpx delivery systems as potential weapons to improve cytarabine treatment response against acute myeloid leukemia |
2021-10-01 |
10.1136/jitc-2021-itoc8.8 |
Nair R, Baldauf H |
| 750563 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.10 FocuSCOPE: a single cell, multi-omics solution to simultaneously analyze tumor variants and microenvironment |
2021-10-01 |
10.1136/jitc-2021-itoc8.22 |
Arjmand Abbassi Y, Fang N, Zhu W, Zhou Y, Chen Y, Deutsch U |
| 750562 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P06.03 Bispecific antibody-driven synthetic agonistic receptor engineered T cells lead to specific and conditional therapy in melanoma cancer models |
2021-10-01 |
10.1136/jitc-2021-itoc8.37 |
Benmebarek M, Märkl F, Keyl J, Loureiro Cadilha B, Geiger M, Karches C, Endres S, Klein C, Kobold S, Klüver A, Schwerdtfeger M |
| 750561 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells |
2021-10-01 |
10.1136/jitc-2021-itoc8.1 |
Cadilha BL, Benmebarek MR, Dorman K, Oner A, Lorenzini T, Obeck H, Stoiber S, Huynh D, Märkl F, Seifert M, Manske K, Endres S, Kobold S |
| 750560 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P06.06 Enhancing trafficking and resistance to immunosuppression of synthetic agonistic receptor-transduced T cells in solid tumor models |
2021-10-01 |
10.1136/jitc-2021-itoc8.40 |
Schwerdtfeger M, Benmebarek M, Märkl F, Karches CH, Öner A, Geiger M, Cadilha B, Endres S, Desiderio V, Klein C, Kobold S |
| 750559 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.03 Automated cell type specific PD-L1 quantification by artificial intelligence using high throughput bleach & stain 15-marker multiplex fluorescence immunohistochemistry in human cancers |
2021-10-01 |
10.1136/jitc-2021-itoc8.15 |
Blessin NC, Bady E, Mandelkow T, Yang C, Raedler J, Simon R, Fraune C, Lennartz M, Minner S, Burandt E, Höflmayer D, Sauter G, Weidemann SA |
